2021
DOI: 10.1016/j.carbpol.2020.117312
|View full text |Cite
|
Sign up to set email alerts
|

Design of oral intestinal-specific alginate-vitexin nanoparticulate system to modulate blood glucose level of diabetic rats

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
9
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 15 publications
(10 citation statements)
references
References 45 publications
1
9
0
Order By: Relevance
“…A schematic presentation of alginate-based material preparation for cancer therapy is shown in Figure 4 . Shaedi et al designed an oral gut specific alginate nano-system for vitexin [ 115 ]. In the study, stearic acid was used to make the matrix hydrophobic, which promotes the early release of vitexin, and the nanoparticles are compacted with polyethylene glycol (PEG3000, 10,000 and 20,000).…”
Section: Biomedical Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…A schematic presentation of alginate-based material preparation for cancer therapy is shown in Figure 4 . Shaedi et al designed an oral gut specific alginate nano-system for vitexin [ 115 ]. In the study, stearic acid was used to make the matrix hydrophobic, which promotes the early release of vitexin, and the nanoparticles are compacted with polyethylene glycol (PEG3000, 10,000 and 20,000).…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…In the study, stearic acid was used to make the matrix hydrophobic, which promotes the early release of vitexin, and the nanoparticles are compacted with polyethylene glycol (PEG3000, 10,000 and 20,000). The results showed that compacting the nanoparticles with PEG significantly reduced the release of vitexin in the gastric region, while the release of vitexin in the intestinal tract increased by the nanoparticles loaded with stearic acid [ 115 ]. The use of PEG-10,000 during the compaction process will lead to PEG-nanoparticle interactions, thereby inhibiting the initial release of vitexin.…”
Section: Biomedical Applicationsmentioning
confidence: 99%
“…1(a)). 10,12,22 The mPEG-g-CTS/ALG nanoparticles showed characteristic peaks at 2800-3000 cm −1 (C H stretching) and 1740 cm −1 (C O of the ester bond) belonging to mPEG-g-CTS 33 and oil. 40 They also showed peaks at 1625 cm −1 (asymmetric COO − ) and 1409 cm −1 (symmetric COO − ) that belong to mPEG-g-CTS/ALG polyelectrolyte complexes 33 (Fig.…”
Section: Chemical Structurementioning
confidence: 99%
“…catalase 17 and nifedipine, 19 increasing their bioavailability and preventing unnecessary interactions with other substances. Crude extract 20,21 and pure vitexin forms 16,22 have previously been encapsulated in various biopolymer shells, including a mixture of κ-carrageenan and sodium carboxymethyl cellulose 20 ; alginate (ALG), ALG-stearic acid and ALG-stearic acid conjugate nanoparticles 22 ; chitosantripolyphosphate particles with and without an ALG-calcium chloride matrix coating 21 ; and bilayer nanoparticles assembled from soybean peptides coated with N-trimethylchitosan coupled to the goblet cell targeting peptide CSKSSDYQC 16 through different methods, including spray drying 20,22 and ionotropic gelation. 14,21 Chitosan and ALG are good biopolymer candidates for shells or particulate carriers due to their nontoxicity, biocompatibility, biodegradability, natural abundance and ability to form particles through polyelectrolyte complexation without toxic crosslinkers.…”
Section: Introductionmentioning
confidence: 99%
“…Unfortunately, extremely low water dissolubility and intestinal first-pass effects significantly with low bioavailability prevent Vi applications [17]. So far, several drug nano-delivery systems (NDDS) have been prepared to improve the aqueous solubility of Vi, viz., β-cyclodextrin inclusion complexes [18], alginate nanoparticles [19] and Vi nanoparticles [20]. However, micelle delivery system of Vi has not been reported to improve bioavailability and anti-osteoporotic effect.…”
Section: Introductionmentioning
confidence: 99%